@article{008e2e842cae4a3a9276eb5c7dcdeab5,
title = "Ceramic microdischarge arrays with individually ballasted pixels",
abstract = "A ceramic microdischarge arrays with individually ballasted pixels was discussed. It was found that spatially uniform glow excited states of the singly charged Xe ion, lying ∼ 26-27 eV above the neutral ground state were observed. The analysis showed that for a 169 element array drawing a total current of 30 mA, the output power of the array in the 300-1000 nm spectral region falls to ∼ 55\% of its initial value in ∼ 8.3h of continuous operation with a static gas fill.",
author = "\{Von Allmen\}, P. and McCain, \{S. T.\} and Ostrom, \{N. P.\} and Vojak, \{B. A.\} and Eden, \{J. G.\} and F. Zenhausern and C. Jensen and M. Oliver",
note = "Funding Information: Colesevelam is an effective nonabsorbed lipid-lowering agent that significantly reduces LDL cholesterol levels and favorably affects total cholesterol, HDL cholesterol, and apolipoprotein B levels. Colesevelam produced a rapid therapeutic response and was well tolerated in the current trial, suggesting that patient compliance will be affected favorably. The mechanism of action, a physiological response to a nonabsorbed agent, may account for the excellent tolerability profile of colesevelam. Thus, colesevelam appears to be a useful therapeutic alternative for patients with mild to moderate primary hypercholesterolemia. We thank the investigators from the 18 clinical trial centers, including Dr Harold Bays (Louisville Metabolic and Atherosclerosis Research Center, Louisville, Ky), Dr Carlos A. Dujovne (Kansas Foundation for Clinical Pharmacology, Overland Park), Dr Stephen P. Glasser (USF, Cardiovascular Unit for Research and Education, Tampa, Fla), Dr Bruce R. Gordon (The Rogosin Institute, New York, NY), Dr Jonathan L. Isaacsohn (Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio), Dr Thomas W. Littlejohn III (Piedmont Medical Research Associates, Winston-Salem, NC), Dr James M. McKenney (National Clinical Research, Inc, Richmond, Va), Dr John Morgan (Thomas Jefferson Cardiology Clinic, Philadelphia, Pa), Dr Eli Roth (University of Cincinnati Medical Center, Cincinnati, Ohio), Dr Dennis Sprecher (The Cleveland Clinic Foundation, Cleveland, Ohio), Dr Danny Sugimoto (Cedar-Crosse Research Center, Chicago, Ill), Dr Stuart R. Weiss (San Diego Endocrine \& Medical Clinic, San Diego, Calif), and Dr James Zavoral (Preventative Cardiology Institute, Edina, Minn). ",
year = "2003",
month = apr,
day = "21",
doi = "10.1063/1.1565186",
language = "English (US)",
volume = "82",
pages = "2562--2564",
journal = "Applied Physics Letters",
issn = "0003-6951",
publisher = "American Institute of Physics",
number = "16",
}